Top 40 Life Science VC Funds & Investors in Denmark (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Novo Holdings
VC Fund
|
5 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.9M–$135M |
|
2xN
VC Fund
|
5 | Denmark, United States, Finland | Seed, Series A, Series B | Software, Information Technology, Quantum Computing | $1.9M–$63M |
|
BioInnovation Institute
VC Fund
|
4 | Denmark, Germany, Switzerland | Convertible Note, Pre-Seed, Seed | Biotechnology, Medical, Health Care | $495k–$5.2M |
|
Export and Investment Fund
VC Fund
|
3 | Denmark, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Health Care | $457k–$43M |
|
Bioqube Ventures
VC Fund
|
3 | United States, France, Norway | Seed, Series A, Series B | Biotechnology, Therapeutics, Life Science | $4M–$108M |
|
Nordic Alpha Partners
VC Fund
|
2 | Denmark, Germany, Sweden | Seed, Series A | Energy, Energy Storage, Manufacturing | $3M–$15M |
|
VF Venture
VC Fund
|
2 | Denmark, United Kingdom, Iceland | Seed, Series A | Software, SaaS, Biotechnology | $1.2M–$22M |
|
Seventure Partners
VC Fund
|
2 | France, United States, Germany | Series A, Series B | Biotechnology, Health Care, Software | $3.3M–$63M |
|
Sunstone Life Science Ventures
VC Fund
|
2 | Denmark, Sweden, Switzerland | Series A, Series B | Biotechnology, Health Care, Medical | $5.5M–$52M |
|
ATP
VC Fund
|
1 | Denmark | Series B | Health Care, Health Diagnostics, Software | |
|
Balderton Capital
VC Fund
|
1 | United Kingdom, United States, Germany | Series A, Series B, Series C | Software, Financial Services, Artificial Intelligence | $5M–$150M |
|
Korys
VC Fund
|
1 | Belgium, The Netherlands, Germany | Series B, Series A | Biotechnology, Renewable Energy, Information Technology | $3.9M–$50M |
|
People Ventures
VC Fund
|
1 | Denmark, Sweden, United States | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $1M–$21M |
|
Innovation Fund Denmark
VC Fund
|
1 | Denmark, United States | Grant, Pre-Seed, Seed | Software, Biotechnology, SaaS | $35k–$1.6M |
|
Ysios Capital
VC Fund
|
1 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$135M |
|
Sound Bioventures
VC Fund
|
1 | United States, United Kingdom, France | Series A, Seed | Biotechnology, Medical, Therapeutics | $18M–$83M |
|
Nucleus Capital
VC Fund
|
1 | Germany, United Kingdom, United States | Pre-Seed, Seed, Series A | Biotechnology, Food and Beverage, Life Science | $125k–$7.4M |
|
Redstone.VC
VC Fund
|
1 | Germany, Finland, Switzerland | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $460k–$17M |
|
2degrees
VC Fund
|
1 | Denmark, Vietnam | Seed, Venture - Series Unknown | Software, Logistics, Quantum Computing | $1.9M–$11M |
|
Lundbeckfonden Ventures
VC Fund
|
1 | United States, Denmark, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $10M–$95M |
|
Dreamcraft Ventures
VC Fund
|
1 | Denmark, United Kingdom, Germany | Seed, Pre-Seed, Series A | Software, Information Technology, Artificial Intelligence | $200k–$16M |
|
Delphinus Venture Capital
VC Fund
|
1 | Denmark | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Food and Beverage, Wellness | $1.7M–$8.1M |
|
Industrifonden
VC Fund
|
1 | Sweden, United States, Denmark | Series A, Seed | Biotechnology, Software, Information Technology | $1.2M–$21M |
|
HealthCap
VC Fund
|
1 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $5.7M–$92M |
|
p53
VC Fund
|
1 | Norway, Denmark | Series A | Biotechnology, Medical, Life Science | $30M–$81M |
|
RA Capital Management
VC Fund
|
1 | United States, United Kingdom, Canada | Series B, Series C, Post-IPO Equity | Biotechnology, Health Care, Therapeutics | $27M–$240M |
|
Danske Bank
VC Fund
|
1 | Sweden, Finland, United Kingdom | Post-IPO Debt, Debt Financing | Manufacturing, Energy, FinTech | $1.1M–$928M |
|
PSV
VC Fund
|
1 | Denmark, United States, United Kingdom | Seed, Pre-Seed | Software, Information Technology, SaaS | $353k–$4.6M |
|
Vaekstfonden
VC Fund
|
1 | Denmark, United States, United Kingdom | Seed, Pre-Seed | Software, Information Technology, SaaS | $384k–$5.3M |
|
Noble Resources
VC Fund
|
1 | Denmark, United Kingdom | Medical, Health Care, Genetics | ||
|
Amino Collective
VC Fund
|
1 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | $125k–$37M |
|
SLS Venture
VC Fund
|
1 | Denmark, United States, Sweden | Series C, Series A | Health Care, Biotechnology, Medical | $6.3M–$15M |
|
BlueYard Capital
VC Fund
|
1 | United States, Germany, United Kingdom | Seed, Series A, Pre-Seed | Software, Biotechnology, Blockchain | $200k–$47M |
|
+ND Capital
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $10M–$100M |
|
GGV Capital
VC Fund
|
1 | United States, China, Singapore | Series B, Series A, Series C | Software, Information Technology, Artificial Intelligence | |
|
Swisscanto Private Equity
VC Fund
|
1 | Switzerland, Germany, Belgium | Series B, Series C | Health Care, Manufacturing, Robotics | |
|
LF Investment
VC Fund
|
1 | Denmark | Series C | Medical, Wellness, Health Care | |
|
Biofund
VC Fund
|
1 | Canada, Denmark, Russian Federation | Seed | Genetics, Medical, Health Care | |
|
Innovestor
VC Fund
|
1 | Finland, Sweden, Denmark | Seed, Pre-Seed | Software, Health Care, Information Technology | $204k–$4.5M |
|
Verve Ventures
VC Fund
|
1 | Switzerland, Germany, France | Series A, Seed, Series B | Health Care, Software, Biotechnology | |
| Access all 99 VC funds in Denmark Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 369
- Round size: Series A $9.9M–$133M; Series B $12M–$135M; Series C $30M–$118M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- PTC Therapeutics — Translating Science. Transforming Lives.
- Tarveda Therapeutics — Developing Pentarins to make a difference in the treatment of patients with solid tumor malignancies
- Tarsa Therapeutics — Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.
2xN operates as a venture capital firm.
Show more...Investment focus
- Industry: Software, Information Technology, Quantum Computing
- Stage:Seed, Series A, Series B
- Geography: Denmark, United States, Finland
Investor stats
- Total investments: 35
- Round size: Seed $1.9M–$6.9M; Series A $6.4M–$63M; Series B $15M–$50M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- QSimulate — QSimulate is a simulation platform that solves pressing problems for the chemical and pharmaceutical industries. It aims to deliver best-time-to-solution algorithms to chemical and pharmaceutical industries to accelerate their computational R&D. It is headquartered in Cambridge, Massachusetts.
- Sparrow Quantum — Sparrow Quantum, a global leader in quantum photonic chip technology. Explore innovative solutions driving advancements in quantum computing, communication, and beyond. Stay ahead with cutting-edge technologies shaping the future.
BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Convertible Note, Pre-Seed, Seed
- Geography: Denmark, Germany, Switzerland
Investor stats
- Total investments: 92
- Round size: Seed $532k–$1.6M; Pre-Seed $516k–$5.2M; Convertible Note $495k–$1.6M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- Visibuilt — Visibuilt develops sustainable, bio-based asphalt binders made from mycelium. Replace fossil bitumen with visiBIT.
- Loma Therapeutics — Loma Therapeutics is developing targeted immunotherapy for the effective and safe treatment of HPV infection, dysplasia, and cancer patients.
- metaLead Therapeutics — metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.
Denmark's Export and Investment Fund (EIFO) serves as a single point of contact for Danish firms seeking risk-tolerant government finance. We aspire to help successful enterprises that can expand the Danish economy and green the world on a daily basis, guided by professionalism and an international perspective.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 136
- Round size: Seed $457k–$11M; Series A $5.9M–$43M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
- MATR Foods — MATR Foods is a food-tech startup that provides fungi-based food ingredients offering dishes produced from fungi like mushrooms, vegetables, and fruits.
- VentriJect — VentriJect is a is a research facility that incorporates measuring cardiorespiratory fitness into everyone's checkup. They estimate respiratory fitness, which is a simple process. As a health indicator, people can increase their cardiorespiratory fitness. They have compiled a list of some of the other pertinent articles that relate to thesignificance of VO2-max measurement.
Bioqube Ventures is a specialist life sciences venture capital fund investing in European biotech companies developing innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.Bioqube Venturesinvests through its independent fund “Bioqube Factory Fund I”: … an early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.… a fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. … a hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.Medtech, healthtech and diagnostics are not part of our current investment scope.
Show more...Investment focus
- Industry: Biotechnology, Therapeutics, Life Science
- Stage:Seed, Series A, Series B
- Geography: United States, France, Norway
Investor stats
- Total investments: 18
- Round size: Seed $5.7M–$24M; Series A $4M–$76M; Series B $23M–$108M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
- Spica Therapeutics — Spica Therapeutics is a pioneering biotech company dedicated to transforming macrophage biology into breakthrough therapies for patients across multiple therapeutic areas. Leveraging its proprietary functional macrophage fingerprinting technology, Spica identifies and selectively targets disease-relevant macrophage sub
- Primmune Therapeutics — Primmune Therapeutics is developing small molecule, orally-administered toll-like receptor 7 (TLR7) agonists to attack tumors and potentiate adaptive cancer immunotherapies, such as checkpoint inhibitors, to improve overall response rates and treatment durability.
Targeting critical European re-industrialisation technology across pioneering hardware sectors with capital efficient growth investments.
Show more...Investment focus
- Industry: Energy, Energy Storage, Manufacturing
- Stage:Seed, Series A
- Geography: Denmark, Germany, Sweden
Investor stats
- Total investments: 27
- Round size: Seed $3M–$8.7M; Series A $15M–$15M
- Lead/follow: 70% lead, 30% follow
- Last fund: May invest from a new fund soon — raised $148M in 2017
Portfolio highlights
- Re-Match — Developer of a recycling technology intended to separate synthetic turf into raw components. The company's technology is based upon a mechanical separation which can recycle the entire turf system while avoiding waste products, enabling organizations to dispose of the old turf in an environmentally friendly way and save money at the same time.
- Green Hydrogen Systems — GreenHydrogen believes that electrolysers have a great potential to become a core technology in green and renewable energy.
- Hybrid Greentech — Hybrid Greentech offers end-to-end profitable solutions for BESS projects, from detailed business case and sizing analysis to project development services, EPC management, and operations and optimization for multi-market revenue stacking.
Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.
Show more...Investment focus
- Industry: Software, SaaS, Biotechnology
- Stage:Seed, Series A
- Geography: Denmark, United Kingdom, Iceland
Investor stats
- Total investments: 30
- Round size: Seed $1.2M–$9.1M; Series A $3.5M–$22M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Rokoko — Rokoko | Affordable high-end motion capture and animation tools for body, hand, and face capture + software with native integrations for all major animation software and game engines
- Kollektiv — Unleash your best self with tailored training plans, learning and support for running, swimming and cycling - from world-class-coaches and ex-athletes.
- Performativ — Performativ develops modern solutions for the asset and wealth management industry. Our clients span from small investment advisors to enterprise banks.
Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B
- Geography: France, United States, Germany
Investor stats
- Total investments: 247
- Round size: Series A $3.3M–$28M; Series B $3.4M–$63M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Ekstere — Ekstere facilitates selling and purchasing verified-quality used bicycles at a reasonable price.
- Pitchy — Create professional videos without technical expertise. Our online video editor helps you easily make business videos.
- Presto Engineering — We enable companies imagine and implement microelectronics solutions in high-value markets such as Industrial, Automotive, Communication and Medical.
Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Denmark, Sweden, Switzerland
Investor stats
- Total investments: 61
- Round size: Series A $5.5M–$44M; Series B $9.6M–$52M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $94M in 2019
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Resalis Therapeutics — Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
ATP is a self-governing institution, established by the Folketing by law in 1964. ATP's Board of Directors consists of equal representatives of employers and employees and an independent chairman of the board. The ATP Group has approx. 3,000 employees. ATP is headquartered in Hillerød, customer service centers in Frederikshavn, Holstebro,Haderslev, Vordingborg, Lillerød and Hillerød, as well as offices in Copenhagen, Allerød and New York.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Software
- Stage:Series B
- Geography: Denmark
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- DSV — Connect your business with the world: Global transport and logistics - road, air, sea, rail freight and warehousing. Contact us today.
- MedTrace Pharma — MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
- Visiopharm — Visiopharm image analysis and stereology software has become the preferred Quantitative Digital Pathology solution for leading biopharmaceutical companies, contract research organizations (CRO), academic medical centers, research institutes, and hospitals all over the world. Recently, Visiopharm has expanded to include ONCOtopix™ Dx a robustsolution for cancer diagnostics with CE-IVD algorithms for the breast panel, integrated LIS driven workflow, and Virtual Double Staining. Their software is featured in over 800 scientific publications, and is compatible with leading slide scanner manufacturers, data management software, and a wide variety of microscopes and cameras.Visiopharm, a privately owned company, was founded in 2001 by the Managing Director, and Chief Executive Officer, Michael Grunkin and the Chief Technical officer, Johan Doré Hansen, who both have a strong scientific and practical background in image analysis.Their company has grown into an international business with over 500 licenses in more than 30 countries. Their growing network of authorized distributors and partners support the growth of Visiopharm solutions on several continents including North America, Europe and Asia. Their headquarters is located in the Medicon Valley of Denmark, with a branch office in the Netherlands, and a North America office in Broomfield, Colorado.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!In the two decades since our founding, we have worked with hundreds of extraordinary European founders, and have raised eight funds totalling more than $3bn.
Show more...Investment focus
- Industry: Software, Financial Services, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 405
- Round size: Series A $5M–$30M; Series B $9.6M–$100M; Series C $15M–$150M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $615M in 2024
Portfolio highlights
- Exein — Exein develops embedded cybersecurity solutions designed to secure Internet of Things (IoT) and connected devices. The company provides a platform that integrates security directly into the firmware of embedded systems, enabling real-time threat detection, monitoring, and response. Exein’s technology focuses on runtime protection and behavioranalysis at the edge, helping manufacturers secure devices without requiring major hardware changes or external software agents. Its solution is compatible with widely used real-time operating systems (RTOS) and Linux-based environments, allowing for flexible integration across different devices. The company also offers tools for vulnerability assessment and threat intelligence tailored for firmware-level defense. Exein supports developers with APIs and SDKs to incorporate security features during the product development phase. Through its platform, the company addresses growing security risks in critical sectors such as automotive, industrial automation, and consumer electronics.
- Writer — WRITER is the enterprise AI agent platform trusted by Fortune 500 companies, built to help teams execute and scale on-brand, compliant work.
- Wayve — Wayve are pioneering an AI-centric approach to self-driving, inspired by our vision of a smarter, safer and more sustainable world.
Korys is the name chosen by the Colruyt family for their investment structure. The name Korys is derived from the Latin word for hazelnut tree – Corylus - which is at the origin of the Colruyt name.Their multi-disciplinary approach enables us to create a well-balanced, diversified portfolio of listed stocks and bonds, private equity funds, anddirect participations in small and medium-sized companies. Through their investments, they aim to make a positive impact on people and the planet, while generating attractive returns. A “three P” approach (People, Planet, Profit) forms the cornerstone of their investment strategy. They invest for the long term, as they realize that it takes time to achieve the sustainable impact they are aiming for. They focus their investments in sectors in which they have built substantial expertise as a team: Cleantech, consumer goods & retail and life sciences.
Show more...Investment focus
- Industry: Biotechnology, Renewable Energy, Information Technology
- Stage:Series B, Series A
- Geography: Belgium, The Netherlands, Germany
Investor stats
- Total investments: 48
- Round size: Series A $3.9M–$13M; Series B $6.4M–$50M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Entrix — Entrix is an optimisation and trading platform for grid-scale battery storage that accelerates the transition towards a clean energy future. Our mission is to enable the most effective use of green energy and to ensure the reliability of the future energy system. We provide state-of-the-art technology and services to both asset owners and potentialinvestors across the globe.
- OroraTech — From safeguarding forests and ecosystems to protecting communities and critical assets, OroraTech's advanced technology and reliable insights address challenges, mitigate risks, and drive meaningful impact.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
We invest ourselves and money into early-stage founders. Operational VC based in Copenhagen, backing pre-seed and seed tech companies across the Nordics.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Denmark, Sweden, United States
Investor stats
- Total investments: 36
- Round size: Seed $1.1M–$19M; Pre-Seed $1M–$1.6M; Series A $3.5M–$21M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- Alrik — Turn your logistics into a competitive advantage and take control of your emissions. We help building material suppliers revolutionize their workflows.
- Passendo — Passendo is the leading email ad server and platform for publishers and advertisers: unlock new revenue with powerful targeting and delivery.
- Pandektes — Legal Research, redefined.
Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Grant, Pre-Seed, Seed
- Geography: Denmark, United States
Investor stats
- Total investments: 96
- Round size: Seed $66k–$1.3M; Grant $35k–$1.2M; Pre-Seed $64k–$1.6M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Prezio — Access comprehensive electricity tariff data across Europe via one API
- PerPlant — PerPlant gives tractors the ability to see every plant. AI-powered cameras that cut input costs by 50% on average.
- SureShot — SureShot empowers you and your audience to become video co-creators. With our cutting-edge AI, capture, edit, and share electrifying videos that amplify the essence of every event.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 81
- Round size: Series A $3.8M–$62M; Series B $20M–$135M; Series C $27M–$80M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Inbiomotion — Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions.Inbiomotion's uniquediagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patients that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
Sound Bioventures is a venture capital fund investing in clinical stage companies.
Show more...Investment focus
- Industry: Biotechnology, Medical, Therapeutics
- Stage:Series A, Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 12
- Round size: Series A $18M–$83M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Cytospire Therapeutics — Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
Supporting purpose-driven founders solving systemic challenges to planetary health.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Life Science
- Stage:Pre-Seed, Seed, Series A
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 28
- Round size: Seed $3M–$7.4M; Pre-Seed $125k–$3M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
- Ucaneo — We Leveraging the magic of the human body to remove CO2 from the air.
- Izote Biosciences — Biomanufacturing Scale-Up Solution
The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Finland, Switzerland
Investor stats
- Total investments: 177
- Round size: Seed $460k–$8M; Pre-Seed $1M–$4.4M; Series A $1.6M–$17M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $57M in 2023
Portfolio highlights
- Nomerra — The AI Coworker in Private Market Operations
- LimX Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
- Zhuji Dynamics — Zhuji Dynamics is a general-purpose footed robot company that focuses on the R&D and manufacturing of sports intelligence and footed robots
Purposeful and profitable capital for extraordinary ventures solving our world's greatest challenges.
Show more...Investment focus
- Industry: Software, Logistics, Quantum Computing
- Stage:Seed, Venture - Series Unknown
- Geography: Denmark, Vietnam
Investor stats
- Total investments: 3
- Round size: Seed $1.9M–$11M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- SmartSolar — SmartSolar is a Saigon-based EnergyTech company working to decarbonise Southeast Asia. With SmartSolar, businesses save on their electricity bill from day 1. SmartSolar is currently busy building the critical financing infrastructure to get SMBs equipped with solar energy. We help our customers save money and enable our partners to reach morecustomers. Renewable energy is at an inflection point across the region and we are on a mission to make it available for everyone.
Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 70
- Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $16M–$53M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
- SNIPR Biome — We are the CRISPR Microbiome Company; Our mission is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.
- Women in Life Science Denmark — WiLD is a networking platform for women in senior positions in business and academia that is motivating and focused on science.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Seed-to-A engineers. We invest in techdriven companies in the Nordics and Europe.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Denmark, United Kingdom, Germany
Investor stats
- Total investments: 49
- Round size: Seed $200k–$4.3M; Pre-Seed $500k–$3.1M; Series A $10M–$16M
- Lead/follow: 53% lead, 47% follow
- Last fund: May invest from a new fund soon — raised $30M in 2014
Portfolio highlights
- Zellify — Zellify is a constructing Web2App infrastructure.
- Leadfamly — The gamification platform for marketers to create immersive brand experiences. Join hundreds of global brands making marketing playable >>
- GamerzClass — A new beginning for GamerzClass
Delphinus Venture Capital is a venture investment management firm.
Show more...Investment focus
- Industry: Health Care, Food and Beverage, Wellness
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Denmark
Investor stats
- Total investments: 12
- Round size: Seed $1.7M–$3.4M; Venture - Series Unknown $1.9M–$8.1M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Alcolase — Alcolase is developing a liposomal enzyme system designed to support alcohol metabolism in the stomach. Copenhagen-based biotech backed by Ada Ventures and Delphinus Venture Capital.
- Oktogrid — Electrification is taking place at a rate, where conventional methods for inspection, maintenance, and congestion management no longer match the new energy scenario. Distribution transformers are ageing blind spots today with no access to online, real-time performance data. This is because getting access to data is hard. We have solved this problem.
- Ardos — Ardos is a developer of radiotherapy software designed to enhance cancer treatment.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Biotechnology, Software, Information Technology
- Stage:Series A, Seed
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 197
- Round size: Seed $1.2M–$6.2M; Series A $3.3M–$21M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Yangi — Yangi is a provider of environmentally friendly packaging solutions.
- Fyndiq — Fyndiq is an e-commerce platform through which we offer a range of products for bargain hungry shoppers. We provide a sales channel for all types of e-tailers who want to boost their sales in an accessible way. Through Fyndiq individual retailers can effect fully sell of its overstock, while consumers have a one stop shop for bargain productsonline. Fyndiq offers more then 220 000 products to consumers from over 1 100 merchants in Sweden. Fyndiq was founded in Stockholm in August 2009 and launched its platform in august 2010. Since then we have been growing rapidly both in terms of turnover and employees. In 2012 our sales was 56 million SEK, a number we doubled in 2013 to sales of almost 124million SEK. In November 2014 Fyndiq raises $20M to take the platform internationally. The funding is notable in that it was led by one of the more prominent VCs based in the Nordics, Northzone, which was an early investor in Spotify. The other investor in this round, Industrifonden, is a VC backed by the Swedish government that invests in startups from the country to help scale them internationally. Currently we are 75 dedicated and motivated team members who make it all happen.
- Avtal24 — Avtal24 offers in an easily accessible manner agreements for both private individuals and companies. They believe in making the law available to everyone and they want everyone to have access to legal security. With us, you write agreements online or together with a lawyer by phone. Always at a fixed price. With high legal expertise, innovativetechnology and great focus on customer benefit and offer the market's most accessible legal services.Avtal24 was founded in 2004 and is headquartered in Stockholm, Sweden.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 133
- Round size: Series A $5.7M–$85M; Series B $12M–$92M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $209M in 2019
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
p53 identifies and invests in innovative healthcare companies, particularly in the fields of biotechnology and medical devices.
Show more...Investment focus
- Industry: Biotechnology, Medical, Life Science
- Stage:Series A
- Geography: Norway, Denmark
Investor stats
- Total investments: 2
- Round size: Series A $30M–$81M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Calluna Pharma — Join Calluna Pharma to transform therapeutics for inflammatory and fibrotic diseases. With a robust pipeline, seasoned leadership, and strategic alliances, we can revolutionize patient care.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series C, Post-IPO Equity
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 518
- Round size: Series B $27M–$152M; Series C $44M–$183M; Post-IPO Equity $35M–$240M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
- Kinaset Therapeutics — Kinaset Therapeutics is a therapeutics company that focuses on the advancement of novel drugs in areas of unmet medical needs. The company was founded in 2020 and is headquartered in Medfield, Massachusetts.
Danske Bank is a Nordic universal bank offering a full range of banking services. It was founded 5 October 1871 as Den Danske Landmandsbank, Hypothek- og Vexelbank i Kjøbenhavn (The Danish Farmers' Bank, Mortgage and Exchange Bank of Copenhagen). It is headquartered in Copenhagen, Denmark and is one of the major retail banks in the northernEuropean region with over 5 million retail customers.Danske Bank was number 454 on the Fortune Global 500 list for 2011.
Show more...Investment focus
- Industry: Manufacturing, Energy, FinTech
- Stage:Post-IPO Debt, Debt Financing
- Geography: Sweden, Finland, United Kingdom
Investor stats
- Total investments: 66
- Round size: Post-IPO Debt $3.4M–$571M; Debt Financing $1.1M–$928M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Bonava — Bonava is a real estate company. They offer apartments and single-family housing to consumers and rental apartments to investors. It constructs several types of homes, such as multi-family housing, single-family homes, and semi-detached houses with various types of tenure.
- Nivika — Nivika is a real estate company that builds and manages properties.
- Donnelly Group — NI's Largest Family Owned Motor Retailer - Established in 1947.
PSV cares about a conscious future. As a venture house, our mission is to clear the path for founders who build companies that matter. Our hybrid setup, comprising PSV Foundry, PSV Lab, and two unique venture funds, PSV Tech and PSV Hafnium, sets us free from adhering to a singular method. Rather we rethink existing ways and models to maximise our impact beyond any individual firm or investment. Together, we can punch above our weight.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 149
- Round size: Seed $500k–$4.6M; Pre-Seed $353k–$2.5M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $42M in 2020
Portfolio highlights
- Woba — Woba is a SaaS aiming to support a stress-free work environment and minimise sick leave.
- Jabbr — Jabbr allows to capture boxing matches with a virtual video production.Its goal is to make video production and advanced performance analytics in combat sports available to anyone with a smartphone.
- eloomi — eloomi is an LMS platform for your workplace to train, retain & engage employees. Explore impactful learning & development today.
Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: Denmark, United States, United Kingdom
Investor stats
- Total investments: 209
- Round size: Seed $830k–$5.3M; Pre-Seed $384k–$1.2M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Deskwolf — Desk Wolf helps SMEs to take advantage of Facebook to generate more sales, more customers, and promote their business in an efficient manner.
- Advalight — Advalight is a young, dynamic company dedicated to providing high-quality laser equipment for dermatological treatments. The company has patented an innovative technology for use in the removal of vascular lesions, acne treatment, skin rejuvenation and many other skin-enhancing procedures. The ground-breaking product was launched the summer 2014.Advalight is based on five years of scientific work in the Physics Department at the Technical University of Denmark. The founders include two PhDs and it is their research that forms the basis of Advalight. The company's main focus is on research and development and with the right external partners we believe that the market for dermatological lasers will be transformed. Advalight is therefore seeking collaboration with external partners with established distribution and sales channels.
- CrossEyes — CrossEyes is a Danish optician chain founded in Aarhus in 2010. Our frames are only available in CrossEyes stores and the designs are inspired by current trends and the Scandinavian simplicity.We believe that glasses are not just a tool to see better: They are a fashion accessory and reflects personality and individual style. We get newcollections 10-12 times annually to make sure there’s always news on the shelves – from the everyday classic Original frame to the colorful and trendy Limited.Our vision is to change the eyewear and optical world. We offer a unique customer experience through stunning eyewear, honest pricing, and legendary service. We do this by putting the customer first in every aspect of our business, as we see our customers as ambassadors for our glasses. We strive to give them the best service possible – every time.
KEDAI69 menghadirkan pengalaman bermain yang seru dengan beragam pilihan permainan menarik untuk dinikmati, serta kenali pola permainan, atur strategi dengan bijak dan temukan peluang terbaik dalam setiap puataran.
Show more...Investment focus
- Industry: Medical, Health Care, Genetics
- Geography: Denmark, United Kingdom
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Exiqon — Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and thedevelopment of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.
- Digital-Healthcare — Digital Healthcare is a health care company. The company has been acquired by EMIS Group.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 45
- Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
- Modern Relay — Modern Relay provides context graph for enterprise AI.
- Theorema — Autonomous R&D agents for biotech, pharma, chemicals, and materials. Theorema analyzes data, recovers R&D costs, and accelerates discovery. #1 on BixBench.
SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish National Pension Fund, Medicon Valley Capital and Innoventus. The fund is one of the largest investment funds in Scandinavia in the life science sector with approx. € 270 M (USD 325 M) under management.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series C, Series A
- Geography: Denmark, United States, Sweden
Investor stats
- Total investments: 6
- Round size: Series C $6.3M–$15M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- AdvanDx — I found a great domain name for sale on Dan.com. Check it out!
- OxThera — OxThera is a biopharmaceutical company with products in late stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria, and enzymes. Oxabact® holds Orphan Drug designations in Europe and in the US for thetreatment of primary hyperoxaluria.
- Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
BlueYard backs founders building the interconnected elements that can become the fabric of our future.
Show more...Investment focus
- Industry: Software, Biotechnology, Blockchain
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 112
- Round size: Seed $1.2M–$14M; Pre-Seed $200k–$5.4M; Series A $7M–$47M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $185M in 2022
Portfolio highlights
- Rapidata — Fast and reliable data labeling that powers your AI. Define your label needs now and get the results in minutes.
- Blockspace — Blockspace is an Ethereum infrastructure company operate out-of-protocol transaction pipelines.
- Blockspace — Connecting the world to Ethereum.
+ND Capital (NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 68
- Round size: Series A $10M–$60M; Series B $13M–$100M; Series C $12M–$67M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $335M in 2019
Portfolio highlights
- Euphrates Vascular — Euphrates Vascular is a medical device company using nanotechnology to optimize flow and treat distal vessel occlusions in Acute Ischemic Stroke (AIS), Peripheral Artery Disea and ST Elevated Myocardial Infarction (STEMI).
- SPARK Microsystems — SPARK UWB Technology enables ultra-low-latency, high-speed wireless for AI glasses, spatial computing, gaming, audio, and IoT devices.
- Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
We believe the talent to build great companies comes from anywhere. A global venture capital firm that invests in local founders. As a multi-stage, sector-focused firm, GGV focuses on seed- to growth-stage investments across Social/Internet, Enterprise Tech, and Smart Tech sectors.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series B, Series A, Series C
- Geography: United States, China, Singapore
Investor stats
- Total investments: 653
- Lead/follow: no public data
Portfolio highlights
- Mind Network — The 1st Fully Homomorphic Encryption (FHE) Restaking Layer for AI and POS Networks. Mind Network is backed by Binance Labs, Hashkey, Big Brain, Chainlink, etc.
- Supermom — Supermom helps parents make the right decisions on what to buy and where to buy at the lowest prices. Best prices guaranteed for millions of mom, baby & kids products.
- Botai Automation — Botai Automation is specialized in CNC system research and development. Its CNC system can be used in machine tools, including drilling and tapping machines, turning and milling compound machining centers and their control accuracy, stability, and performance outperform earlier products of the same type.
We invest in growth companies in the "late-stage venture/growth capital" phase, focussed on the technology and healthtech sectors.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Robotics
- Stage:Series B, Series C
- Geography: Switzerland, Germany, Belgium
Investor stats
- Total investments: 30
- Lead/follow: no public data
Portfolio highlights
- Fotokite — Specialized actively tethered UAS built for First Responders, providing immediate situational awareness of an emergency scene.
- Memo Therapeutics — Memo Therapeutics AG (MEMO) is an innovator in the field of antibody discovery and immune repertoire analysis.Its MemoMAB™ platform creates a recombinant in vitro copy of an individual’s B cell / antibody repertoire, which is then banked as a library. The resulting unique, large and relevant antibody libraries represent the individual’simmune repertoire and are expected to contain an unprecedented number of relevant and rare antibodies. This leads to entirely new possibilities in immune repertoire analysis and antibody discovery.MemoMAB™ is deployed in proprietary antibody lead discovery programs and is made available in collaborations.
- NIL Technology ApS — NIL Technology is an optical solutions company designing, developing, and manufacturing optical elements and components using high-precision nanoscale features
LF Investment is the investment arm of The Lauritzen Foundation, which is the parent company of the shipping companies J. Lauritzen (wholly-owned) and DFDS (42,8% holding). LF Investment has holdings in companies in the oil analysis, measuring equipment, software, biotechnology, and real estate sectors.
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Series C
- Geography: Denmark
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Minervax — We are MinervaX. A clinical stage biotech company focused on making a global impact by developing state-of-the-art vaccines.
BIOFUND SpA, established by Fondazione Monte dei Paschi, Bank Monte dei Paschi , Finanziaria Senese di Sviluppo e Fidi Toscana, provides the initial seed capital for companies located in the incubator of Toscana Life Sciences in Siena.
Show more...Investment focus
- Industry: Genetics, Medical, Health Care
- Stage:Seed
- Geography: Canada, Denmark, Russian Federation
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Exiqon — Exiqon operates in two business areas: Life Sciences and Diagnostics. Exiqon Life Sciences, a leading provider of flexible solutions for RNA analysis. Exiqon’s research products are used by academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and thedevelopment of cancer and other diseases. Exiqon Diagnostics collaborates with pharmaceutical and diagnostic companies to develop novel molecular diagnostic tests for early detection of diseases which can help physicians make treatment decisions based on the tools developed by Exiqon Life Sciences.
- RTM Diagnostika — Diagnostic microwave radio RTM-01-RESThe temperature and rate of growth of malignant tumorsCancer is the terrible disease of breast. That is why the full range of diagnostic measures in mammalogy aimed primarily at identifying it. It is known that the malignant tumor has a higher temperature compared with surrounding tissues. These data werefirst obtained Guture M. French scientist, who, after more than 550 invasive measurements demonstrated that malignancy is determined by its temperature is doubling time. Therefore, the most dangerous, rapidly growing tumors have a very high temperature. It is also known that thermal changes, usually preceded by structural changes. In particular, the thermal changes of the mammary glands come not a moment when the cancer reaches the required size, but much earlier. Studies have shown that even at the stage preceding the malignant growth, namely, when the cells have the expressed proliferation, accompanied by atypical changes, increases the density of microcapillary network, and as a consequence there is a local increase in temperature. Indisputable is the fact that patients with these changes have a high risk of malignancy. Many authors classify this condition as precancerous.The internal temperature - measure of angiogenesisIn 2003, Japanese scientists have shown that the temperature in the cancerous region determined by the density microcapillary network (microvessel density (MVD) [8]. This is the main parameter that characterizes angiogenesis. The density of the microcapillary network when proliferation atypia several times greater than the rate for normal tissues and characterizes the risk of malignancy. in addition, the microcapillary network density refers to the probability of transformation from noninvasive to invasive cancer, the probability of metastasis and tumor growth rate. Therefore, the internal temperature, as a measure of angiogenesis, provides important information about the development of cancer.
- Genizon BioSciences — Since 2005, we have helped thousands of people get the perfect domain name.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 89
- Round size: Seed $478k–$4.5M; Pre-Seed $204k–$2M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Retailgrid — Agentic AI pricing platform for mid-market retailers. Turn messy retail data into structured, explainable price decisions in days, not months.
- Bahn Express — Euroopan nopein autojen kuljetus. Autoliikkeille, autokauppiaille ja kalustonhallintaan. Euroopan halki 72 tunnissa.
- Cornea Sense — CorneaSense is a medtech startup developing a non-invasive, eye-based sensing device that measures ocular surface hydration to enable early detection and monitoring of conditions such as dry eye disease and systemic health disorders. The technology aims to provide real-time, objective eye biomarkers for improved clinical diagnosis and patient care.
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 230
- Lead/follow: no public data
Portfolio highlights
- Otoqi — Otoqi is a vehicle delivery platform that develops connected services and logistics solutions for the automotive professionals.
- tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
- Orakl Oncology — Cultivated with love by the Orakl team.
Life Science VC funding in Denmark at a glance
Stats across 72 deals from 99 investors.
Access all 99 VC funds in Denmark Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Denmark investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 99 VC funds investing in Denmark Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!